Controversial CRISPR paper earns second editorial note … – Retraction Watch (blog)
High Point Observer |
Controversial CRISPR paper earns second editorial note …
Retraction Watch (blog) Against the authors' objections, Nature Methods has added an expression of concern to a 2017 paper that drew fire for suggesting a common gene editing … $-0.42 EPS Expected for Intellia Therapeutics (NTLA), Colony … Intellia Therapeutics (NTLA) Reaches $17.68 After 3.00% Up Move … -$0.42 EPS Expected for Intellia Therapeutics, Inc. (NASDAQ:NTLA … |
